Table 2.
Control | Exercise | LPS | Exercise+LPS | P | |
---|---|---|---|---|---|
IL-6 BALF | 0.015 ± 0.002 | 0.011 ± 0.005 | 0.541 ± 0.445a | 0.767 ± 0.664 | <0.001 |
IL-6 plasma | 0.016 ± 0.008 | 0.011 ± 0.003 | 0.096 ± 0.029a | 0.059 ± 0.037 | ≤0.001 |
IL-10 BALF | 0.009 ± 0.032 | 0.050 ± 0.048 | 0.066 ± 0.072 | 0.056 ± 0.041 | ns |
IL-10 plasma | 0.013 ± 0.034 | 0.058 ± 0.278 | 0.351 ± 0.176a | 0.111 ± 0.215 | 0.027 |
IL-1β BALF | 0.150 ± 0.033 | 0.106 ± 0.060 | 0.161 ± 0.186a | 0.357 ± 0.246b | <0.02 |
KC BALF | 0.017 ± 0.011 | 0.013 ± 0.007 | 0.596 ± 0.233a | 0.626 ± 0.121 | <0.001 |
TNF-α BALF | 0.018 ± 0.016 | 0.028 ± 0.018 | 0.027 ± 0.017 | 0.032 ± 0.029 | ns |
a indicates the significant effect of LPS in increasing cytokine levels; b indicates the significant interaction effect of LPS and exercise in increasing the cytokine level; values are means ± SD. BALF, bronchoalveolar lavage fluid; LPS, lipopolysaccharide; ns, non-significant.